A quick look back at 2020

“Securing the Series B round enables Miracor to start its early commercialization strategy with (1) enrollment into the RAMSES trials, (2) European reimbursement, and (3) sales activities. We also are very pleased to be supported by AWS and the new investor SHS.” Jon H. Hoem, CEO, Miracor Medical Systems


Click here to read the full press release.

Categories:

Comments are closed

Newsletter Signup

Subscribe to our monthly newsletter below and never miss the latest news about CEO-CF